Physician profile

Allen Hu

Houston, TX

NPI 1780267658

$3,091.10

in general payments reported to CMS, 2019-2025

6 companies · $2,966 in 2025

The $2,966 reported for 2025 was more than what 96% of providers received nationally.

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$1,640.31
Travel and Lodging$1,306.87
Education$143.92

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $2,683.92 2025 Gallant, Perclose Prostyle, Ensite
Bridgebio Pharma, INC. $143.05 2025 Attruby
Amgen INC. $124.98 2024 Repatha
Cvrx, INC. $103.57 2025 Barostim Neo System
Boston Scientific Corporation $21.91 2025 Accolade Sr
Pfizer INC. $13.67 2025

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Allen Hu

$3,091.10

in general payments reported 2019-2025

Years
2024-2025
Top company
Abbott Laboratories
Context
The $2,966 reported for 2025 was more than what 96% of providers received nationally.

https://glasscript.com/doctor/11919095/allen-hu

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.